APOL1 and chronic kidney disease: By examining each two-risk-variant genotype individually rather than grouping them together, we detect complexities in the relationship between APOL1 risk variants and CKD, suggesting that APOL1-mediated cell injury in CKD might be a result of more than one genotype-specific molecular pathway.